Ticker
ICCCCompany Name
IMMUCELL CORPSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Earning Before Interest & Taxes (EBIT) | Enterprise Value | Enterprise Value over EBIT |
---|---|---|---|
6/30/2025 | $ 1.77M | $ 69.05M | 38.95 |
3/31/2025 | $ -261.16K | $ 54.43M | 0 |
12/31/2024 | $ -2.15M | $ 56.34M | 0 |
9/30/2024 | $ -3.81M | $ 43.18M | 0 |
6/30/2024 | $ -4.05M | $ 43.97M | 0 |
3/31/2024 | $ -3.89M | $ 58.09M | 0 |
12/31/2023 | $ -5.77M | $ 56.09M | 0 |
9/30/2023 | $ -6.3M | $ 55M | 0 |
6/30/2023 | $ -6.01M | $ 52.53M | 0 |
3/31/2023 | $ -5.31M | $ 48.55M | 0 |
EV / EBIT
(=) EV/EBIT
EV/EBIT for IMMUCELL CORP is calculated as follows: EV [ $ 46.62M ] / EBIT [ $ -1.54M ]
(=) EV/EBIT [ 0 ]
Minimum
Jun 30, 2025
Maximum
Sep 30, 2021
Average
Median
filtered constituents | 2.25K |
---|---|
min | 0.05 |
max | 62.03 |
average | 19.91 |
median | 16.78 |
std | 12.32 |